CHINWAGYThe world's live brand collaboration wire
Join freeCreatorsIndustryContact
For you +
ReadersCreatorsBrands & IndustryContact Chinwagy

THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Teva and Polpharma Biologics global licensing agreement for an Ocrevus biosimilar candidate

Teva×Polpharma Biologics

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Teva’s newsroom reports a global licensing agreement with Polpharma Biologics for a biosimilar candidate to Ocrevus.

Current status
Official collaboration
Known availability
The published source describes the collaboration; timing details remain under review.
Place
International, International
Source checked
September 27, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.